-Reuters
Aileron Therapeutics Q4 EPS $(0.08) Up From $(0.12) YoY
Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(0.08) per share. This is a 33.33 percent increase over losses of $(0.12) per share from the same period last year.